Mental Health

Clinical trials shouldn't feel like a cold call

Stigma keeps patients from picking up the phone. TrialScreen uses SMS-first screening to remove the pressure of a cold call, meet participants after hours, and match across your full psychiatric portfolio — all in one conversation.

See How It Works →
The Challenge

Why mental health trials struggle to enroll

Traditional outreach methods clash with the realities of psychiatric patient populations.

Stigma and Call Avoidance

Patients dealing with depression, anxiety, and PTSD are less likely to answer unknown phone numbers. Cold calls feel intrusive during vulnerable periods, and voicemail callbacks are rare.

Complex Psychiatric Criteria

Protocols span MDD, GAD, PTSD, bipolar disorder, and schizophrenia — each with overlapping but distinct inclusion/exclusion criteria. Manual screening misses nuances across conditions.

After-Hours Need

37% of patient interactions happen outside business hours. Anxiety and depression symptoms peak in the evening, exactly when coordinators aren’t available to answer questions.

The Solution

How TrialScreen changes the approach

SMS-First Reduces Anxiety

Text-based screening removes the pressure of a phone call. Participants respond on their own terms, in their own time, without the anxiety of speaking to a stranger about their mental health.

24/7 AI Handles After-Hours

When a participant texts at 11 PM during an anxiety episode, TrialScreen responds immediately. No voicemail, no callback queue, no lost engagement window.

Portfolio Matching Across Indications

A participant screened for an MDD trial who doesn’t qualify may match a GAD or PTSD study in your portfolio. TrialScreen checks every active protocol in a single interaction.

By the Numbers

The mental health enrollment gap

37%

of patient interactions after business hours

Industry data

85.6%

of patients prefer text over phone

JAAOS, 2021

80%

of trials miss enrollment timelines

JMIR, 2020

57%

drop in enrollment efficiency in 2022

CenterWatch, 2022

Indications

Supported mental health indications

TrialScreen screens across your full psychiatric portfolio in a single interaction.

MDDTreatment-Resistant DepressionGADPTSDBipolar DisorderSchizophreniaOCDADHD

See how TrialScreen works for mental health trials

Book a demo and we'll run a live screening session against your psychiatric protocol.